Andrea Corcoran

Insider Reports History

Location
Boston, MA
Signature
/s/ Andrea Corcoran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrea Corcoran:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Chief Financial Officer, Executive Vice President, Legal and Secretary Common Stock 763,576 $3,237,562 $4.24 31 Jan 2026 Direct
Atea Pharmaceuticals, Inc. Chief Financial Officer, Executive Vice President, Legal and Secretary Restricted Stock Units 0 $32,130 $3.06 31 Jan 2026 Direct
Atea Pharmaceuticals, Inc. Chief Financial Officer, Executive Vice President, Legal and Secretary Stock Option (Right to Buy) 180,000 31 Jan 2026 Direct

Insider Reports Filed by Andrea Corcoran

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2026 5 -$68,281 4 Chief Financial Officer, Executive Vice President, Legal and Secretary 03 Feb 2026, 19:46
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2025 6 -$49,272 4 Chief Financial Officer, Executive Vice President, Legal and Secretary 04 Feb 2025, 18:00
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2024 4 -$60,915 4 Chief Financial Officer, Executive Vice President, Legal and Secretary 02 Feb 2024, 21:31
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2023 2 $0 4 Chief Financial Officer, Executive Vice President, Legal and Secretary 02 Feb 2023, 17:30
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2022 1 $0 4 Chief Financial Officer, Executive Vice President, Legal and Secretary 02 Feb 2022, 16:15